Half of those surveyed plan to raise deductibles and maximum out-of-pocket costs for workers. Read more at straitstimes.com. Read more at straitstimes.com.

Eli Lilly’s stock closed at $771.75, slipping 3.45% and lagging the broader market. The company’s shares fell despite outperforming the medical sector over the past month. Analysts eagerly await its ...

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...

A Nigerian-born health data scientist, David Ajayi, is making waves in the United States through nationally recognized work ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by ...

President Donald Trump is keeping up the pace with seemingly a new tariff development every day. This time, he flagged that ...

Medical schools must make microbiology a prerequisite — to prepare students not just for school but for practicing medicine.

A new $5.5 million grant will fund STEM programs and career pathways for IPS middle and high school students starting at ...

Are Indianapolis and Fort Wayne becoming popular cities for young professionals to move to? According to LinkedIn, both ...

Alright, listen to me. This one is one that everyone’s going to give up on. Then one day, it’s going to be up 300, I’m not ...

"Pharmaceuticals will be tariffed probably at the end of the month, and we're going to start off with a low tariff and give the pharmaceutical companies a year or so to build, and then we're going to ...

A promising experimental drug is one more sign of the impending disruption the booming Chinese biotech industry could bring ...